Pharmafile Logo

Video: Immuno-oncology therapies

June 3, 2016 | immuno-oncology 


Immuno-oncology therapies which harness the body’s own defences to fight off tumours are widely acknowledged as the new frontier in cancer treatment. However, these therapies come with a very high price tag and currently only a few of these drugs have actually reached the market including Opdivo, Keytruda and Yervoy. In this video Director Sue Marett discusses the opportunities and challenges for new immuno-oncology therapies and outlines what these mean for pharma market research.

http://www.researchpartnership.com/news/2016/05/video-immuno-oncology-therapies/

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Webinar: The Brazil Conundrum

Conducting research in one of the world's largest pharma markets

Webinar: Demand calibration: What’s inside the black box?

The process of demand calibration of preference share (down-weighting) is often a proprietary "black box" technique, which can mean that the client is unsure how the calibrated figure has been...

Free Thinking: Behavioural economics

Our Free Thinking white paper asks, does behavioural economic theory have a role to play in pharmaceutical market research?

Article: The Colombia Conundrum

Published in eye for pharma 30 January by Marc Yates

Ageing in China: The Implications for Healthcare

Published in eye for pharma 12 December by Marc Yates

Pegasus picks up “Specialist Consultancy of the Year” at the PRCA Awards 2014

Pegasus, the UK’s leading independent health communications consultancy, picked up the “Specialist Consultancy of the Year” award at the PRCA Awards 2014.

Pegasus supports unique theatrical performance as part of the 9th UK Dementia Congress

Brighton-based Pegasus, the UK’s leading independent health communications consultancy, is pleased to be supporting Naomi’s Flight - a bold and unique theatrical performance tour that highlights the impact of dementia...

It’s a hat trick for Pegasus!

Pegasus scoops the much-coveted “Consultancy of the Year” prize at the PR Week Awards 2014

Exploring MINT: Part 4 – Turkey

In the fourth and final of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in...